The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effects of Board Games on Balance in Association With Cognition in Community-Dwelling Elderly.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06047769
Recruitment Status : Completed
First Posted : September 21, 2023
Last Update Posted : May 21, 2024
Sponsor:
Information provided by (Responsible Party):
Riphah International University

Brief Summary:
As age progress incidence of fall increases. Cognitively impaired patients have poor balance and they are more prone to falls. Balance and cognitive functions are co-related in middle-aged and community-dwelling elderly. In fact age-related cognitive decline as the brain ages it has exceptional neuroplasticity. To maintain balance and prevent falls various cognitive processes are required. Board games can be used as tools for cognitive training as they have the means to restore and form motor skills, cognitive functioning, and logical and spatial thinking. Cognitive training using simple games might improve the elements of balance and gait, and prevent falls.

Condition or disease Intervention/treatment Phase
Geriatric Population Other: Board Games Not Applicable

Detailed Description:

In fact age-related cognitive decline, as the brain ages, it has exceptional neuroplasticity. This can be achieved by cognitive training which consists of domain-specific task completion or exercises to promote neurogenesis in that domain. Cognitive training is an approach towards enhancing neural plasticity by focusing on and training cognitive domains for balance improvement. Board games can be used as tools for cognitive training as they have the means to restore and form motor skills, cognitive functioning, and logical and spatial thinking. A board game is a generic term for a game played by placing, moving or removing pieces on a board and that utilizes a game format in which pieces are moved in particular ways on a board marked with a pattern. As a tool, board games can improve comprehension and cognitive functioning among participants.

As per a study, computer-based cognitive training by simple games such as Road Tour, Jewel Diver, and Sweep Seeker improved visuospatial memory, speed of processing and inhibition which in turn improved balance and gait, and prevented falls in community-dwelling elderly but as per the author's access, there's lack of standardization in terms of types of cognitive training program intended to improve balance in the elderly population by using simple board games. Hence, the author established the research question of whether is this technique effective in the elderly population in terms of its effects on cognition and balance to prevent falls. This study will provide insight to the clinician on whether board games-based cognitive training improves balance and prevents fall risk in the elderly population.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 64 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Board Games on Balance in Association With Cognition in Community-Dwelling Elderly.
Actual Study Start Date : September 22, 2023
Actual Primary Completion Date : December 31, 2023
Actual Study Completion Date : January 30, 2024

Arm Intervention/treatment
Experimental: Interventional Group
Participants will receive cognitive training in board games including Ludo, Chutes & Ladder and Chess with both single and multiplayer modes. After 1 week of training, participants will receive intervention of 1 hour per day, three days a week for 8 weeks completing a total of 1440 minutes. With this technique, we will target the cognitive process of information processing, speed and executive function of the patient.
Other: Board Games
Participants will receive cognitive training in board games including Ludo, Chutes & Ladder and Chess with both single and multiplayer modes. After 1 week of training, participants will receive intervention of 1 hour per day, three days a week for 8 weeks completing a total of 1440 minutes. With this technique, we will target the cognitive process of information processing, speed and executive function of the patient.

No Intervention: Control group
Participants will receive no intervention and will be observed for 8 weeks.



Primary Outcome Measures :
  1. Berg Balance Scale (BBS) [ Time Frame: Baseline ]
    A testing tool with high validity ( 0.93) and reliability (0.98) was used to measure balance in the elderly. The Berg Balance Scale (BBS) is a valid tool. The total score for the BBS is 56 and a higher score means good balance. It will be measured at baseline, 4th week and 8th week.

  2. Berg Balance Scale (BBS) [ Time Frame: After 4 weeks ]
    A testing tool with high validity ( 0.93) and reliability (0.98) was used to measure balance in the elderly. The Berg Balance Scale (BBS) is a valid tool. The total score for the BBS is 56 and a higher score means good balance. It will be measured at baseline, 4th week and 8th week.

  3. Berg Balance Scale (BBS) [ Time Frame: After 8 weeks ]
    A testing tool with high validity ( 0.93) and reliability (0.98) was used to measure balance in the elderly. The Berg Balance Scale (BBS) is a valid tool. The total score for the BBS is 56 and a higher score means good balance. It will be measured at baseline, 4th week and 8th week.

  4. Mini-Mental State Exam (MMSE) [ Time Frame: Baseline ]
    A set of 11 questions that doctors and other healthcare professionals commonly use to check for cognitive impairment (problems with thinking, communication, understanding and memory) with reliability of (0.98) and reliability (0.77). The Mini-Mental State Exam (MMSE) is a valid tool. It will be measured at baseline, 4th week and 8th week. The total score for the MMSE is 30 and a higher score means good cognition.

  5. Mini-Mental State Exam (MMSE) [ Time Frame: After 4 weeks ]
    A set of 11 questions that doctors and other healthcare professionals commonly use to check for cognitive impairment (problems with thinking, communication, understanding and memory) with reliability of (0.98) and reliability (0.77). The Mini-Mental State Exam (MMSE) is a valid tool. It will be measured at baseline, 4th week and 8th week. The total score for the MMSE is 30 and a higher score means good cognition.

  6. Mini-Mental State Exam (MMSE) [ Time Frame: After 8 weeks ]
    A set of 11 questions that doctors and other healthcare professionals commonly use to check for cognitive impairment (problems with thinking, communication, understanding and memory) with reliability of (0.98) and reliability (0.77). The Mini-Mental State Exam (MMSE) is a valid tool. It will be measured at baseline, 4th week and 8th week. The total score for the MMSE is 30 and a higher score means good cognition.


Secondary Outcome Measures :
  1. Dynamic Gait Index (DGI) [ Time Frame: Baseline ]
    A clinical tool to assess gait, balance and fall risk with reliability of (0.98). The Dynamic Gait Index (DGI) is a valid tool. It will be measured at baseline, 4th week and 8th week. The total possible score is 24. A lower score indicates greater impairment or a higher risk of falls.

  2. Dynamic Gait Index (DGI) [ Time Frame: After 4 weeks ]
    A clinical tool to assess gait, balance and fall risk with reliability of (0.98). The Dynamic Gait Index (DGI) is a valid tool. It will be measured at baseline, 4th week and 8th week. The total possible score is 24. A lower score indicates greater impairment or a higher risk of falls.

  3. Dynamic Gait Index (DGI) [ Time Frame: After 8 weeks ]
    A clinical tool to assess gait, balance and fall risk with reliability of (0.98). The Dynamic Gait Index (DGI) is a valid tool. It will be measured at baseline, 4th week and 8th week. The total possible score is 24. A lower score indicates greater impairment or a higher risk of falls.

  4. Timed Up & Go test (TUG) [ Time Frame: Baseline ]
    It is a quick and widely used clinical performance-based measure of lower extremity function, mobility and fall risk with a specificity of 0.70 sensitivity of 0.57(17) and reliability of (0.98). The Timed Up & Go test (TUG) test is a valid tool. The TUG is timed. The score is the time (in seconds) it takes the person to complete the task, starting from the command "Go" and stopping when the person is seated back in the chair. Times greater than 13.5 seconds are often associated with a higher risk of falls. It will be measured at baseline, 4th week and 8th week.

  5. Timed Up & Go test (TUG) [ Time Frame: After 4 weeks ]
    It is a quick and widely used clinical performance-based measure of lower extremity function, mobility and fall risk with a specificity of 0.70 sensitivity of 0.57(17) and reliability of (0.98). The Timed Up & Go test (TUG) test is a valid tool. The TUG is timed. The score is the time (in seconds) it takes the person to complete the task, starting from the command "Go" and stopping when the person is seated back in the chair. Times greater than 13.5 seconds are often associated with a higher risk of falls. It will be measured at baseline, 4th week and 8th week.

  6. Timed Up & Go test (TUG) [ Time Frame: After 8 weeks ]
    It is a quick and widely used clinical performance-based measure of lower extremity function, mobility and fall risk with a specificity of 0.70 sensitivity of 0.57(17) and reliability of (0.98). The Timed Up & Go test (TUG) test is a valid tool. The TUG is timed. The score is the time (in seconds) it takes the person to complete the task, starting from the command "Go" and stopping when the person is seated back in the chair. Times greater than 13.5 seconds are often associated with a higher risk of falls. It will be measured at baseline, 4th week and 8th week.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   60 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Males and Female participants aged 60 years or older.
  • Score of 26 or more on the Mini-Mental State Examination (MMSE)
  • At least one self-reported fall within the last 2 years or (BBS) score less than 52 and more than 41.
  • Subjects who are willing to commit to the time commitments required by the program.

Exclusion Criteria:

  • Those who will not meet the inclusion criteria.
  • Presence of any physical limitation that may limit hand movement.
  • Presence of a severe walking or balance impairment For Example; (Amputation, or Fracture at that time.)
  • Self-reported presence of vertigo
  • Any visual disease
  • Currently using psychotropic medications.
  • Presence of any neurological disorder

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06047769


Locations
Layout table for location information
Pakistan
ABID Hospital
Islamabad, Pakistan, 46000
Sponsors and Collaborators
Riphah International University
Investigators
Layout table for investigator information
Principal Investigator: Imran Amjad, PhD Riphah International University
Publications:
Layout table for additonal information
Responsible Party: Riphah International University
ClinicalTrials.gov Identifier: NCT06047769    
Other Study ID Numbers: REC01539 Muhammad Ammar
First Posted: September 21, 2023    Key Record Dates
Last Update Posted: May 21, 2024
Last Verified: May 2024
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No